ADVERTISEMENT
Shuttered Abbott Units Ink $160M Deal In FCA Case, DOJ Says
Law360 (August 2, 2021, 7:54 PM EDT) A now-defunct diabetic testing equipment supplier last owned by Abbott Laboratories will cough up $160 million to settle claims that it wrongly paid kickbacks and also charged Medicare for unnecessary equipment, according to the federal government.
Arriva Medical LLC and its parent company, Alere Inc., have agreed to the settlement in the False Claims Act case, in which the U.S. Department of Justice intervened after initially being filed by whistleblower Gregory M. Goodman, according to a Monday announcement from the DOJ. Paying illegal inducements to Medicare beneficiaries in the form of free items and routine copayment waivers can result in overutilization.
Mail Order Diabetes Testing Company Settles FCA Claims with DOJ
lawstreetmedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lawstreetmedia.com Daily Mail and Mail on Sunday newspapers.
Abbott Labs to Pay $160 Mln Over Kickbacks, False Diabetes Claims to Medicare
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
U S hits 70 percent one-dose vaccination benchmark
politico.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from politico.com Daily Mail and Mail on Sunday newspapers.
Abbott Labs paying $160M to settle kickbacks and false diabetes claims
econotimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from econotimes.com Daily Mail and Mail on Sunday newspapers.